Acurx Pharmaceuticals, Inc. (ACXP) Financials
ACXP Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 7.7 million | 3.0 million |
| 2023-09-30 | 7.2 million | 3.2 million |
| 2023-06-30 | 9.2 million | 3.0 million |
| 2023-03-31 | 7.4 million | 2.1 million |
ACXP Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -4.2 million | 833285 |
| 2023-09-30 | -2.1 million | 833285 |
| 2023-06-30 | -1.6 million | 806485 |
| 2023-03-31 | -1.9 million | 899375 |
ACXP Net Income
No data available :(
ACXP Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 7.5 million | - | - |
| 2023-09-30 | 7.1 million | - | - |
| 2023-06-30 | 9.1 million | - | - |
| 2023-03-31 | 7.2 million | - | - |
ACXP Shares Outstanding
ACXP Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | 1.9 million | 3.2 million | - |
| 2023-09-30 | - | 1.3 million | 1.8 million | - |
| 2023-06-30 | - | 1.7 million | 1.7 million | - |
| 2023-03-31 | - | 1.0 million | 1.9 million | - |
ACXP Cost of Revenue
No data available :(
ACXP
Price: $2.17
52 week price:
Earnings Per Share: -1.15 USD
P/E Ratio: -3.04
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 73400
Market Capitalization: 29.3 million